Novartis AG (SWX:NOVN)
133.14
-1.34 (-1.00%)
Nov 11, 2026, 12:40 PM CET
Novartis AG Employees
Novartis AG had 75,267 employees as of December 31, 2025. The number of employees decreased by 616 or 0.81% compared to the previous year. That makes Novartis AG the 453rd largest employer in the world and 7th in Switzerland.
Employees
75,267
Change (1Y)
-616
Growth (1Y)
-0.81%
Revenue / Employee
635.88K CHF
Profits / Employee
111.19K CHF
Market Cap
251.45B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75,267 | -616 | -0.81% |
| Dec 31, 2024 | 75,883 | -174 | -0.23% |
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Alcon | 25,000 |
| Lonza Group AG | 20,141 |
| Sandoz Group AG | 20,000 |
| Sonova Holding AG | 18,590 |
| Straumann Holding AG | 11,582 |
| Galderma Group AG | 7,676 |
| Galenica AG | 6,623 |
Novartis AG News
- 17 hours ago - Novartis' Ianalumab Shows Continued Benefits In Two-Year Sjögren's Study - Nasdaq
- 18 hours ago - Novartis presents long-term results from ongoing NEPTUNUS extension study - TheFly
- 18 hours ago - How IBD Stock Of The Day TG Therapeutics Is Catching Up To Roche, Novartis - Investor's Business Daily
- 1 day ago - Zacks Industry Outlook Highlights Eli Lilly, Novartis and Bayer - Nasdaq
- 1 day ago - A failed trial for a heart drug casts shadow over rivals developing similar therapies - Market Watch
- 2 days ago - Novartis drops heart drug after it failed to prevent heart attacks - Stock Analysis
- 2 days ago - Novartis to discontinue development of pelacarsen, Bloomberg says - TheFly
- 3 days ago - Trial failures of Novartis, Novo Nordisk heart drugs leave experts guessing - Reuters